Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination.

Lee, Adrian Y S; Lee, Caroline; Brown, David A; Suan, Dan

Lee, Adrian Y S; Lee, Caroline; Brown, David A; Suan, Dan.

Afiliación

Lee AYS; Westmead Hospital, Westmead, New South Wales, Australia.
Lee C; Department of Immunopathology, Institute for Clinical Pathology and Medical Research & NSW Health Pathology, Westmead, NSW, Australia.
Brown DA; Westmead Clinical School, The University of Sydney, Westmead, NSW, Australia.
Suan D; Westmead Hospital, Westmead, New South Wales, Australia.

Postgrad Med J ; 99(1170): 363-364, 2023 05 22.

Article en En | MEDLINE | ID: mdl-37227977

Asunto(s)

COVID-19; Dermatomiositis; Humanos; Vacuna BNT162; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; Vacunación

Palabras clave

adult dermatology; immunology; neurology; rheumatology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatomiositis / COVID-19 Límite: Humans Idioma: En Revista: Postgrad Med J Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google